This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aduro Biotech Holdings, Europe B.v.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Paul Maria Frederikus Vink: Innovator in Antibody Development
Introduction
Paul Maria Frederikus Vink is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies.
Latest Patents
Vink holds a patent for an agonistic antibody to CD27. This invention relates to a binding compound that targets the same epitope of human CD27 as the monoclonal antibody hCD27.15. The hybridoma hCD27.15 was deposited with the ATCC on June 2, 2010, under number PTA-11008. The binding compound may include an antibody heavy chain variable region with at least one CDR from specific sequences, as well as an antibody light chain variable region with corresponding CDRs.
Career Highlights
Paul Vink is currently associated with Aduro Biotech Holdings, Europe B.V. His work focuses on innovative approaches to antibody development, which have the potential to advance therapeutic options in various medical fields.
Collaborations
Vink collaborates with esteemed colleagues such as Hans Van Eenennaam and Winfried Robert Mulder, contributing to a dynamic research environment that fosters innovation.
Conclusion
Paul Maria Frederikus Vink is a prominent figure in the biotechnology sector, recognized for his innovative work on therapeutic antibodies. His contributions continue to impact the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile